Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1USV Private Limited
03 1Aurobindo Pharma Limited
04 1DARMERICA, LLC
05 1Divi's Laboratories Limited
06 2Glenmark Life Sciences Limited
07 2Hetero Drugs Limited
08 1MYLAN LABORATORIES LIMITED
09 1Tianish Laboratories Private Limited
10 1Zydus Lifesciences Limited
01 2ATOVAQUONE
02 9Atovaquone
03 1atovaquone
01 10India
02 2U.S.A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-048
Start Marketing Date : 2021-05-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0057
Start Marketing Date : 2009-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-090
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-059
Start Marketing Date : 2007-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-840
Start Marketing Date : 2006-11-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-928
Start Marketing Date : 2016-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0034
Start Marketing Date : 1992-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0159
Start Marketing Date : 1992-11-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-734
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-158
Start Marketing Date : 2024-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Atovaquone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atovaquone, including repackagers and relabelers. The FDA regulates Atovaquone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atovaquone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atovaquone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atovaquone supplier is an individual or a company that provides Atovaquone active pharmaceutical ingredient (API) or Atovaquone finished formulations upon request. The Atovaquone suppliers may include Atovaquone API manufacturers, exporters, distributors and traders.
click here to find a list of Atovaquone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atovaquone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atovaquone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atovaquone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atovaquone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atovaquone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atovaquone suppliers with NDC on PharmaCompass.
We have 10 companies offering Atovaquone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
